Neuropeptide S human (0.1 nM-1 nM; icv) causes a significant increase in locomotor activity, the total distance traveled, percentage of time moving, number of rearing events, and center entries are also significantly increased in mice .
Animal Model: | Male C57Bl/6 mice |
Dosage: | 0.1 nM, 1 nM |
Administration: | Intracerebroventricular (icv) injection |
Result: | Increased locomotor activity and promoted wakefulness. |